Close Menu

NEW YORK – Genetron Health reported on Monday morning that its third quarter revenues were up 38 percent year over year.

The Beijing-based precision oncology firm reported total revenues of RMB112.0 million ($16.5 million) for the quarter ended Sept. 30 compared to RMB81.3 million in the same period of 2019. Wall Street analysts, on average, had estimated revenues of $16.1 million.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

New analyses indicate the P.1 variant found in Brazil may be able to infect people who have already had COVID-19, the New York Times reports.

According to CNBC, Novavax's CEO says its vaccine could be authorized in the US as early as May.

The US National Institutes of Health has a new initiative to address structural racism in biomedical research.

In PNAS this week: GWAS of TLV-1-associated myelopathy/tropical spastic paraparesis, analysis of twins with hypertrophic cardiomyopathy, and more.